Year archive

InnoCan Pharma Corporation — 2026 filings

All 20 regulatory filings released by InnoCan Pharma Corporation (INNO) in 2026, sourced directly from the official regulator.

20 Filings

2026 Period

2026 filings (20)

Filing	Released	Lang
Material change report - English.pdf Regulatory Filings	2026-04-06	English
Material change report - English.pdf Capital/Financing Update	2026-04-06	English
Material change report - English.pdf Regulatory Filings	2026-04-06	English
Material change report - English.pdf Capital/Financing Update	2026-04-06	English
News release - English.pdf M&A Activity	2026-04-06	English
News release - English.pdf Capital/Financing Update	2026-04-06	English
FWP - INNOCAN PHARMA Corp (0001889791) (Subject) Regulatory Filings	2026-04-03	English
News release - English.pdf Capital/Financing Update	2026-03-31	English
News release - English.pdf Capital/Financing Update	2026-03-31	English
News release - English.pdf Earnings Release FY 2025	2026-03-31	English
News release - English.pdf Earnings Release FY 2025	2026-03-31	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Capital/Financing Update	2026-03-31	French
Annual MD&A - English.pdf Management Reports	2026-03-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-03-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-03-30	English
Audited annual financial statements – English.pdf Annual Report FY 2025	2026-03-30	English
NI 44-101 Withdrawal Notice – English.pdf Regulatory Filings	2026-03-30	English
NI 44-101 Withdrawal Notice – English.pdf Regulatory Filings	2026-03-30	English
News release - English.pdf Capital/Financing Update	2026-01-27	English
News release - English.pdf Capital/Financing Update	2026-01-02	English